You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 11, November 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Patient-Physician Relationship/ Care
 •Treatment Adherence
 •Dermatologic Disorders, Other
 •Dermatology, Other
 •Drug Therapy
 •Adherence
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Adherence, the Fourth Dimension in the Geometry of Dermatological Treatment

Bridgit V. Nolan, BA; Steven R. Feldman, MD, PhD

Arch Dermatol. 2009;145(11):1319-1321.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of the Archives, Armstrong et al1 describe a fascinating study that used electronic monitors to determine the effect of text message reminders on sunscreen use. Armstrong et al1 document that even people who know they are being monitored do not use their sunscreen well. Their study has profound implications for how we view our patients' use of sunscreen and other treatments.

When considering how patients respond to our recommendations, there may be a tendency to think in 3 dimensions. These dimensions include the treatment plan, the patient's disease, and how these 2 entities interact over time. When patients are not responding to treatment as expected, we often think their disease must be recalcitrant and that a different treatment is needed. When there are more adverse effects than usual, we conclude that the medication must be particularly irritating . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Text-Message Reminders to Improve Sunscreen Use: A Randomized, Controlled Trial Using Electronic Monitoring
April W. Armstrong, Alice J. Watson, Maryanne Makredes, Jason E. Frangos, Alexandra B. Kimball, and Joseph C. Kvedar
Arch Dermatol. 2009;145(11):1230-1236.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.